FDA Approved: QUETIAPINE — Supplemental Application (Accord Healthcare Inc.)

View source ↗

Summary

The FDA approved Accord Healthcare Inc.'s supplemental application for quetiapine (ANDA 202152), granting approval of a generic quetiapine product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Major Depressive Disorder
• Schizophrenia

Drugs mentioned

• Quetiapine (quetiapine)

Snippet

SUPPL AP for QUETIAPINE (QUETIAPINE)